BioCryst Pharmaceuticals Inc. logo

BioCryst Pharmaceuticals Inc. (BCRX)

Market Open
1 Sep, 19:45
NASDAQ (NGS) NASDAQ (NGS)
$
9. 88
+0.18
+1.8557%
$
2.47B Market Cap
- P/E Ratio
- Div Yield
2.06M Volume
-0.62 Eps
$ 9.7
Previous Close
Add Transaction
Day Range
9.64 9.96
Year Range
6 11.22
Want to track BCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BioCryst Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
201 $1,508.61 $1,813.02 $304.41 20.18%
BZ
Brandon Zatopek Commonwealth Equity Services LLC
66,855 $668,550 $627,099.9 -$41,450.1 -6.2%
ABB
Alexander Bjornager Bonde Danske Bank A/S
2 $19 $18.75 -$0.25 -1.32%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
52 $549.1 $537.68 -$11.42 -2.08%
NA
Nizar Araji National Bank Of Canada /FI/
6,412 $60,065 $60,112.5 $47.5 0.08%
BG
Bart Gancher Intech Investment Management LLC
47,763 $358,650.18 $447,778.12 $89,127.94 24.85%
SR
Shantelle Reidy Ironwood Investment Management LLC
26,500 $176,000 $258,110 $82,110 46.65%
BJK
Brian J. Kopinski Woodmont Investment Counsel LLC
70,201 $473,433.24 $633,213.02 $159,779.78 33.75%
JM
John Malone Amundi
16,944 $169,440 $166,728.96 -$2,711.04 -1.6%
Bridgewater Associates LP
Bridgewater Associates LP Bridgewater Associates LP
491,057 $4.5M $4.78M $278,982.28 6.19%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
260,917 $2.61M $2.54M -$67,838.42 -2.6%
PF
Phillip Fitzsimmons Hennion & Walsh Asset Management Inc.
112,893 $932,844.46 $1.01M $80,934.68 8.68%
Melissa Tiscareno
Melissa Tiscareno Bradley & Co. Private Wealth Management LLC
370 $2,886 $3,468.75 $582.75 20.19%
Matthew Carney
Matthew Carney Nfj Investment Group LLC
278,792 $2.79M $2.88M $94,789.28 3.4%
Joseph Castro
Joseph Castro Nuveen LLC
4.01M $34.03M $41.43M $7.4M 21.75%
Sima Elimelech
Sima Elimelech Activest Wealth Management
2,000 $12,360 $17,960 $5,600 45.31%
Brian Baylis
Brian Baylis Bell Investment Advisors Inc.
107 $661.26 $1,003.66 $342.4 51.78%
SAS
Stephane Astruc/ Salomon Sebban J. Safra Sarasin Holding AG
15,700 $157,047 $140,986 -$16,061 -10.23%
SRB
Steve R. Bailey Frazier Life Sciences Management LP
4.01M $38.17M $39.05M $882,032.8 2.31%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
14 $109.2 $125.72 $16.52 15.13%